Efficiency of Combined Hepatoprotector Forceliv in the Treatment of Chronic Diffuse Liver Disease

Efficiency of Combined Hepatoprotector Forceliv in the Treatment of Chronic Diffuse Liver Disease

The article presents the results of a study of serum alanine aminotransferase levels in patients with chronic diffuse liver diseases on the background of combined hepatoprotector Forceliv application. According to the findings, a significant decrease of this indicator in all examined patients has be...

Full description

Bibliographic Details
Main Authors: Yu.M. Stepanov, Yu.S. Breslavets, I.Yu. Zavyalova, S.V. Kosynska, V.B. Yagmur, N.G. Zaichenko, V.M. Gladun, D.V. Popok, M.L. Pleschenko, S.L. Melanych, O.V. Mosyntseva, I.I. Slakva, L.V. Borodina, V.Yu Poleshko, J.V. Stepanova
Format: Article
Language:English
Published: Publishing House Zaslavsky 2014-11-01
Series:Gastroenterologìa
Subjects:
chronic diffuse liver disease
alanine aminotransferase
hepatoprotector
Forceliv
Online Access:http://gastro.zaslavsky.com.ua/article/view/82048

Internet

http://gastro.zaslavsky.com.ua/article/view/82048

Similar Items